back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-07-06 13:45 Tx date 2026-07-03 |
$LSL
LSL Pharma Group Inc. |
Allard, Guy Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
500,000 | |
| Filed 2026-07-06 13:38 Tx date 2026-07-03 |
$LSL
LSL Pharma Group Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2026-07-06 13:35 Tx date 2026-05-28 |
$LSL
LSL Pharma Group Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-02 11:54 Tx date 2026-07-02 |
$LSL
LSL Pharma Group Inc. |
Allard, Guy Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$160.00
+500 vol $0.32 each |
25,000 | |
| Filed 2026-07-02 11:53 Tx date 2026-06-30 |
$LSL
LSL Pharma Group Inc. |
Allard, Guy Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$1,395
+4,500 vol $0.31 each |
24,500 | |
| Filed 2026-06-19 15:18 Tx date 2026-06-19 |
$LSL
LSL Pharma Group Inc. |
Paradis, Mario
4 - Director of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$46,500
+150,000 vol $0.31 each |
525,000 | |
| Filed 2026-06-18 12:59 Tx date 2026-06-18 |
$LSL
LSL Pharma Group Inc. |
Allard, Guy Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$155.00
+500 vol $0.31 each |
20,000 | |
| Filed 2026-06-16 13:37 Tx date 2026-06-15 |
$LSL
LSL Pharma Group Inc. |
Allard, Guy Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
10 - Acquisition or disposition in the public market
|
$6,045
+19,500 vol $0.31 each |
19,500 | |
| Filed 2026-06-16 13:34 Tx date 2024-11-04 |
$LSL
LSL Pharma Group Inc. |
Allard, Guy Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-28 15:30 Tx date 2026-05-28 |
$LSL
LSL Pharma Group Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
29,487 | ||
| Filed 2026-02-05 20:35 Tx date 2026-02-03 |
$LSL
LSL Pharma Group Inc. |
Laflamme, Louis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,600
+30,000 vol $0.52 each |
280,000 | |
| Filed 2026-02-05 20:32 Tx date 2026-02-03 |
$LSL
LSL Pharma Group Inc. |
Laflamme, Louis
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-92,500
-250,000 vol $0.37 each |
250,000 | |
| Filed 2026-02-04 14:40 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2026-02-04 14:37 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,500,000 | ||
| Filed 2026-02-04 10:02 Tx date 2026-02-03 |
$LSL
LSL Pharma Group Inc. |
Paradis, Mario
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+190,000 vol |
355,000 | |
| Filed 2026-02-04 09:34 Tx date 2026-02-03 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+165,000 vol |
1,645,270 | |
| Filed 2026-02-04 08:47 Tx date 2026-02-03 |
$LSL
LSL Pharma Group Inc. |
Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
160,000 | |
| Filed 2026-02-04 08:47 Tx date 2025-10-16 |
$LSL
LSL Pharma Group Inc. |
Mokaddem, Noureddine
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-02-04 08:42 Tx date 2026-02-03 |
$LSL
LSL Pharma Group Inc. |
Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+190,000 vol |
470,000 | |
| Filed 2023-03-03 23:58 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|